InfuSystem (INFU) Stock Price, News & Analysis

Company Overview

InfuSystem Holdings, Inc. is a leading provider of comprehensive infusion pump and respiratory therapy services to healthcare providers across the United States and Canada. Founded in 1987 and headquartered in Lake Forest, Illinois, the company offers a full suite of rental, sales, service and managed care programs designed to support hospitals, oncology clinics, urology practices and ambulatory infusion centers. InfuSystem’s core business encompasses the supply and maintenance of a broad array of medical devices, including electronic infusion pumps, elastomeric devices, balloon pumps, syringe pumps and portable ventilators tailored to diverse clinical applications.

In addition to its robust rental and sales platform, InfuSystem delivers a range of value-added services such as device maintenance, calibration, inspection, preventive maintenance and end-of-life replacement programs. The company operates a nationwide network of repair and refurbishment facilities, ensuring rapid turnaround times and minimizing downtime for critical medical equipment. InfuSystem’s managed services programs streamline inventory management and regulatory compliance, enabling healthcare providers to focus on patient care while reducing administrative burdens and capital expenditures.

Over the years, InfuSystem has expanded its reach through strategic acquisitions and partnerships, broadening its product offerings and extending its service footprint. The company serves a diverse customer base that includes academic medical centers, community hospitals, outpatient facilities, home infusion providers and physician-owned clinics. With a dedicated team of field service engineers and remote technical support specialists, InfuSystem maintains a high level of responsiveness and personalized customer service.

Led by an experienced executive team with deep expertise in medical device logistics, service operations and healthcare technology integration, InfuSystem continues to innovate in equipment lifecycle management and patient-centric therapy solutions. The company’s ongoing investments in device connectivity, data analytics and telehealth capabilities underscore its commitment to enhancing clinical outcomes and operational efficiencies for healthcare providers.

Key Stats

• Today's Range: $5.80 to $6.22
• 50-Day Range: $4.70 to $6.46
• 52-Week Range: $4.61 to $9.97
• Volume: 51,340 shs
• Average Volume: 116,160 shs
• Market Capitalization: $121.89 million
• P/E Ratio: 96.68
• Dividend Yield: N/A
• Price Target: $13.00
• Consensus Rating: Strong Buy

InfuSystem Stock Analysis - MarketRank™

InfuSystem scored higher than 63% of companies evaluated by MarketBeat, and ranked 376th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Strong Buy

Amount of Analyst Coverage

InfuSystem has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 106.67%

Earnings Growth

Earnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of InfuSystem is 96.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of InfuSystem is 96.68, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.94.

Price to Book Value per Share Ratio

InfuSystem has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.83% of the float of InfuSystem has been sold short.

Short Interest Ratio / Days to Cover

InfuSystem has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in InfuSystem has recently decreased by 73.93%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

InfuSystem does not currently pay a dividend.

Dividend Growth

InfuSystem does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.83% of the float of InfuSystem has been sold short.

Short Interest Ratio / Days to Cover

InfuSystem has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in InfuSystem has recently decreased by 73.93%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.4 / 5
• News Sentiment: N/A

News Sentiment

InfuSystem has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for InfuSystem this week, compared to 1 article on an average week.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $46,629.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

11.40% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

INFU Stock Analysis - Frequently Asked Questions

How have INFU shares performed this year?

InfuSystem's stock was trading at $8.45 at the beginning of 2025. Since then, INFU shares have decreased by 31.4% and is now trading at $5.80.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSE:INFU) announced its quarterly earnings results on Thursday, November, 7th. The company reported $0.08 earnings per share for the quarter, hitting the consensus estimate of $0.08. The company had revenue of $35.32 million for the quarter, compared to analyst estimates of $35.50 million. InfuSystem had a net margin of 1.12% and a trailing twelve-month return on equity of 2.78%.

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 7/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:INFU
• Previous Symbol: NYSE:INFU
• CIK: 1337013
• Web: www.infusystem.com
• Phone: (248) 291-1210
• Fax: 800-455-4338
• Employees: 410
• Year Founded: N/A

Price Target and Rating

• Average Price Target for InfuSystem: $13.00
• High Price Target: $13.00
• Low Price Target: $13.00
• Potential Upside/Downside: +124.1%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 4.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.14
• Trailing P/E Ratio: 96.68
• Forward P/E Ratio: 38.67
• P/E Growth: N/A
• Net Income: $870 thousand
• Net Margins: 1.12%
• Pretax Margin: 2.65%
• Return on Equity: 2.78%
• Return on Assets: 1.41%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 1.98
• Quick Ratio: 1.59

Sales & Book Value

• Annual Sales: $137.58 million
• Price / Sales: 0.89
• Cash Flow: $0.45 per share
• Price / Cash Flow: 12.79
• Book Value: $2.47 per share
• Price / Book: 2.35

Miscellaneous

• Outstanding Shares: 21,016,000
• Free Float: 19,095,000
• Market Cap: $121.89 million
• Optionable: Optionable
• Beta: 1.81